NOWDiagnostics vs Neuralink
Side-by-side comparison of AI visibility scores, market position, and capabilities
NOWDiagnostics develops OTC and point-of-care rapid diagnostic tests using minimal capillary blood or saliva samples; produces the CLIP platform for simultaneous multi-analyte testing;
About
NOWDiagnostics is a diagnostics company headquartered in Springdale, Arkansas, focused on developing and manufacturing over-the-counter and point-of-care rapid diagnostic tests. The company's technology platform uses extremely small sample volumes — capillary blood from a fingerstick or saliva — to deliver fast, accurate results outside traditional laboratory settings. This makes its tests well-suited for home use, pharmacies, urgent care centers, and resource-limited clinical environments where laboratory infrastructure is unavailable or impractical.
Pioneer of implantable BCIs with 12+ active human patients as of Sep 2025; raised $650M Series E in Apr 2026 led by ARK Invest and Sequoia at a ~$14.9B valuation; mass production underway.
About
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with paralysis to control digital devices directly with their thoughts. The company's first commercial product, the N1 implant, is a coin-sized device containing 1,024 electrodes that is surgically placed in the motor cortex. As of September 2025, twelve patients worldwide had received the N1 implant and were actively using it to control computers, smartphones, and robotic arms with neural signals alone.
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.